Supriya Lifescience Ltd Share Price ₹977

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Supriya Lifescience Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	142	132	140	140	158	161	166	186	184	145	200	206	277
Expenses +	87	88	108	99	103	98	101	120	117	93	127	134	179
Operating Profit	55	44	32	41	56	63	65	66	68	52	73	72	98
OPM %	39%	34%	23%	30%	35%	39%	39%	36%	37%	36%	36%	35%	35%
Other Income +	2	3	2	3	2	2	3	2	3	3	3	2	3
Interest	1	1	0	0	1	0	0	1	0	1	0	0	0
Depreciation	3	4	4	4	4	5	5	5	6	6	7	7	8
Profit before tax	53	43	30	40	53	60	62	63	64	47	68	67	92
Tax %	28%	33%	20%	26%	31%	25%	26%	25%	21%	27%	26%	26%	19%
Net Profit +	38	29	24	30	37	45	46	47	50	35	50	50	74
EPS in Rs	4.75	3.54	2.97	3.70	4.59	5.55	5.73	5.81	6.26	4.32	6.27	6.17	9.22

Financials of Supriya Lifescience Ltd

Annual income statement trend

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	184	213	278	312	391	530	461	570	696	828
Expenses +	166	191	213	213	218	316	332	394	436	534
Operating Profit	17	22	65	98	173	214	129	176	261	294
OPM %	9%	10%	23%	32%	44%	40%	28%	31%	37%	36%
Other Income +	7	9	8	11	5	8	9	11	10	11
Interest	12	11	10	7	4	4	3	5	2	2
Depreciation	5	5	5	6	7	10	12	16	20	28
Profit before tax	8	14	57	96	167	207	123	166	248	275
Tax %	30%	40%	31%	24%	26%	27%	27%	28%	24%	24%
Net Profit +	6	9	39	73	124	152	90	119	188	209
EPS in Rs	3.87	5.96	26.93	50.11	16.89	18.86	11.17	14.80	23.35	25.98
Dividend Payout %	0%	0%	0%	20%	3%	3%	5%	5%	4%	4%

Financials of Supriya Lifescience Ltd

Capital structure and asset base

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	15	15	15	15	15	16	16	16	16	16
Reserves	31	40	79	134	254	600	683	799	981	1,182
Borrowings +	140	130	90	82	72	27	22	5	5	5
Other Liabilities +	55	60	69	105	105	92	98	101	110	154
Total Liabilities	241	245	253	336	445	735	820	921	1,112	1,357
Fixed Assets +	89	91	85	99	100	190	262	310	453	689
CWIP	36	34	35	40	79	43	68	149	148	36
Investments	0	0	0	0	0	0	25	64	63	99
Other Assets +	117	120	133	197	267	502	466	399	448	534
Total Assets	241	245	253	336	445	735	820	921	1,112	1,357

Financials of Supriya Lifescience Ltd

Operating, investing and financing cash movement

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	27	28	49	117	76	49	64	113	165
Cash from Investing Activity +	-27	-5	5	-25	-47	-60	-124	-174	-152
Cash from Financing Activity +	-2	-20	-50	-29	-15	150	-10	-22	-8
Net Cash Flow	-2	3	4	62	15	139	-70	-83	4
Free Cash Flow	-0	23	54	92	29	-11	-44	-32	2
CFO/OP	158%	141%	97%	146%	61%	51%	73%	86%	86%

Financials of Supriya Lifescience Ltd

Working capital efficiency and return ratios

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	99	92	79	60	69	79	67	71	70	97
Inventory Days	113	85	77	130	206	172	234	140	205	229
Days Payable	121	112	110	130	145	91	130	98	129	159
Cash Conversion Cycle	91	64	45	61	130	160	171	114	146	167
Working Capital Days	-69	-50	-5	-40	28	117	168	157	144	147
ROCE %		14%	37%	50%	60%	43%	19%	22%	27%	25%